Malaria treatment policy change and implementation: the case of Uganda.

Authors:
Address: Disease Prevention and Control Cluster: World Health Organization, Uganda Country Office, P.O. Box 24578, Kampala, Uganda.
Journal:

Publication:
Free Text: Malaria treatment policy change and implementation: the case of Uganda.

abstract

Malaria due to P. falciparum is the number one cause of morbidity and mortality in Uganda where it is highly endemic in 95% of the country. The use of efficacious and effective antimalarial medicines is one of the key strategies for malaria control. Until 2000, Chloroquine (CQ) was the first-line drug for treatment of uncomplicated malaria in Uganda. Due to progressive resistance to CQ and to a combination of CQ with Sulfadoxine-Pyrimethamine, Uganda in 2004 adopted the use of ACTs as first-line drug for treating uncomplicated malaria. A review of the drug policy change process and postimplementation reports highlight the importance of managing the policy change process, generating evidence for policy decisions and availability of adequate and predictable funding for effective policy roll-out. These and other lessons learnt can be used to guide countries that are considering anti-malarial drug change in future.

Related Articles
Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug.
Malar J. 2005
Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug.
Mubyazi GM, Gonzalez-Block MA. Malar J. 2005 Oct 20; 4:51. Epub 2005 Oct 20.
Increasing antimalarial drug resistance in Uganda and revision of the national drug policy.
Trop Med Int Health. 2002
Increasing antimalarial drug resistance in Uganda and revision of the national drug policy.
Kamya MR, Bakyaita NN, Talisuna AO, Were WM, Staedke SG. Trop Med Int Health. 2002 Dec; 7(12):1031-41.
How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy.
J Ethnobiol Ethnomed. 2006
How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy.
Nsimba SE. J Ethnobiol Ethnomed. 2006 Jan 10; 2:5. Epub 2006 Jan 10.
Review [Combined antimalarial therapy using artemisinin].
Parassitologia. 2004
Review [Combined antimalarial therapy using artemisinin].
Majori G. Parassitologia. 2004 Jun; 46(1-2):85-7.
Review Lessons learnt from the six decades of chloroquine use (1945-2005) to control malaria in Madagascar.
Trans R Soc Trop Med Hyg. 2009
Review Lessons learnt from the six decades of chloroquine use (1945-2005) to control malaria in Madagascar.
Randrianarivelojosia M, Raveloson A, Randriamanantena A, Juliano JJ, Andrianjafy T, Raharimalala LA, Robert V. Trans R Soc Trop Med Hyg. 2009 Jan; 103(1):3-10. Epub 2008 Oct 26.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.